The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Puri-Nethol 50 mg Tablets

Primecrown 2010 LimitedPPA1633/073/001

Main Information

Trade NamePuri-Nethol 50 mg Tablets
Active Substances6-mercaptopurine
Dosage FormTablet
Licence HolderPrimecrown 2010 Limited
Licence NumberPPA1633/073/001

Group Information

ATC CodeL01BB Purine analogues
L01BB02 mercaptopurine


License statusWithdrawn
Withdrawn Date01/07/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back